Co-Diagnostics, Inc.
CODX
$1.55
$0.021.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.59% | 22.05% | 4.20% | 7.79% | -6.53% |
| Total Depreciation and Amortization | -19.63% | -10.26% | 0.16% | 6.59% | 11.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 355.42% | -88.83% | -83.77% | -65.04% | -31.78% |
| Change in Net Operating Assets | -214.98% | -169.87% | -65.18% | -50.19% | -51.17% |
| Cash from Operations | 0.06% | -21.27% | -34.06% | -19.29% | -32.03% |
| Capital Expenditure | 6.44% | 43.76% | 38.41% | 72.42% | 45.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.37% | -0.18% | 14.76% | -81.32% | 6.36% |
| Cash from Investing | 53.91% | 1.70% | 17.36% | -81.66% | 10.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11,268.24% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11,268.24% | 3,197.12% | 372.27% | 152.01% | 107.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 174.69% | 15.87% | -9,864.06% | -226.62% | -48.70% |